| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3127007
Max Phase: Preclinical
Molecular Formula: C30H33NO6
Molecular Weight: 503.60
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccccc1CN(C)CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1
Standard InChI: InChI=1S/C30H33NO6/c1-31(19-22-9-5-6-10-27(22)35-2)15-7-3-4-8-16-36-24-17-26(33)29-28(18-24)37-20-25(30(29)34)21-11-13-23(32)14-12-21/h5-6,9-14,17-18,20,32-33H,3-4,7-8,15-16,19H2,1-2H3
Standard InChI Key: IVDBOZXZGIOCCA-UHFFFAOYSA-N
Associated Targets(Human)
Acetylcholinesterase 18204 Activities
Associated Targets(non-human)
Butyrylcholinesterase 745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acetylcholinesterase 12221 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acetylcholinesterase 2577 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 503.60 | Molecular Weight (Monoisotopic): 503.2308 | AlogP: 5.95 | #Rotatable Bonds: 12 |
| Polar Surface Area: 92.37 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 7.30 | CX Basic pKa: 8.49 | CX LogP: 5.07 | CX LogD: 4.98 |
| Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.23 | Np Likeness Score: 0.13 |
References
| 1. Qiang X, Sang Z, Yuan W, Li Y, Liu Q, Bai P, Shi Y, Ang W, Tan Z, Deng Y.. (2014) Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease., 76 [PMID:24589487] [10.1016/j.ejmech.2014.02.045] |
Source
Source(1):